CMPX financials
Compass Therapeutics (CMPX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- CMPX revenue was $0.00 in fiscal 2025, net income -$66.49M.
CMPX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | – | -$72.84M | -$66.49M | -0.42 |
| 2024 | $850.00K | – | -$56.62M | -$49.38M | -0.36 |
| 2023 | $0.00 | – | -$50.36M | -$42.49M | -0.33 |
| 2022 | – | – | -$41.66M | -$39.23M | -0.37 |
| 2021 | – | – | -$81.88M | -$82.18M | -1.31 |
| 2020 | – | – | -$32.10K | -$37.48K | -0.01 |